Bing Wang , Huihui Tan , Xiuyun Sun , Zizi Lin , Xiayu Chen , Hongguang Han , Mingfang Wang , Zijie Wang , Xiangxiu Chen , Yinyue Deng , Shihao Song
{"title":"Inhibition of Candida albicans virulence by moscatin from Dendrobium nobile lindl.","authors":"Bing Wang , Huihui Tan , Xiuyun Sun , Zizi Lin , Xiayu Chen , Hongguang Han , Mingfang Wang , Zijie Wang , Xiangxiu Chen , Yinyue Deng , Shihao Song","doi":"10.1016/j.micpath.2024.107089","DOIUrl":null,"url":null,"abstract":"<div><div><em>Candida albicans</em> infection poses a significant global health threat. It is imperative to exploit new antifungal agents against <em>C. albicans</em> infections without leading to drug resistance, so that these potential agents can complement or combine with current medications to effectively treat diseases caused by <em>C. albicans</em>. We screened moscatin, and assessed the inhibitory effectiveness against <em>C. albicans</em> SC5314 on hyphae production and biofilm formation. It was revealed that moscatin exhibited significant effects on morphological transition and biofilm formation in <em>C. albicans</em> SC5314. It also lowered the pathogenicity of <em>C. albicans</em> SC5314 in a concentration-dependent way in both A549 cells and mice fungal infection models, but had no cytotoxicity to A549 cells. In addition, moscatin attenuated the virulence of clinical fluconazole-resistant <em>C. albicans</em> and exhibited synergistic activity with fluconazole. It could also restore the composition and richness of the intestinal microbiota in mice infected by <em>C. albicans</em>. These findings indicate that these moscatin has great potential to be developed as a new therapeutic drug against <em>C. albicans</em> infection.</div></div>","PeriodicalId":18599,"journal":{"name":"Microbial pathogenesis","volume":"197 ","pages":"Article 107089"},"PeriodicalIF":3.3000,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Microbial pathogenesis","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0882401024005564","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Candida albicans infection poses a significant global health threat. It is imperative to exploit new antifungal agents against C. albicans infections without leading to drug resistance, so that these potential agents can complement or combine with current medications to effectively treat diseases caused by C. albicans. We screened moscatin, and assessed the inhibitory effectiveness against C. albicans SC5314 on hyphae production and biofilm formation. It was revealed that moscatin exhibited significant effects on morphological transition and biofilm formation in C. albicans SC5314. It also lowered the pathogenicity of C. albicans SC5314 in a concentration-dependent way in both A549 cells and mice fungal infection models, but had no cytotoxicity to A549 cells. In addition, moscatin attenuated the virulence of clinical fluconazole-resistant C. albicans and exhibited synergistic activity with fluconazole. It could also restore the composition and richness of the intestinal microbiota in mice infected by C. albicans. These findings indicate that these moscatin has great potential to be developed as a new therapeutic drug against C. albicans infection.
期刊介绍:
Microbial Pathogenesis publishes original contributions and reviews about the molecular and cellular mechanisms of infectious diseases. It covers microbiology, host-pathogen interaction and immunology related to infectious agents, including bacteria, fungi, viruses and protozoa. It also accepts papers in the field of clinical microbiology, with the exception of case reports.
Research Areas Include:
-Pathogenesis
-Virulence factors
-Host susceptibility or resistance
-Immune mechanisms
-Identification, cloning and sequencing of relevant genes
-Genetic studies
-Viruses, prokaryotic organisms and protozoa
-Microbiota
-Systems biology related to infectious diseases
-Targets for vaccine design (pre-clinical studies)